Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials Post author:Sam Post published:March 4, 2018 Post category:BioPharma Dermira plans to shutter the program and move on to more promising compounds. Source: BioSpace You Might Also Like FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… November 16, 2017 Another Biotech is Born as Bay Area's BridgeBio Pharma Launches With $27 Million April 26, 2017 <b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars May 17, 2017
FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… November 16, 2017
<b>Epicore BioNetworks Inc.</b> Reports Quarter Three Results For Fiscal Year 2017 For The Quarter Ended 31 March 2017, In U.S. Dollars May 17, 2017
